News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Paving the Way for Ultrarare Bone Disease Treatment Trial
May 21, 2024 - NCATS News
- Our Impact on Drug Discovery and Development
- Therapeutics for Rare and Neglected Diseases (TRND)
Clinicians at the NIH Clinical Center will soon start testing an investigative drug for an ultrarare bone disease.
Read ArticleEveryLife Foundation Announces Scientific Workshop on ‘Ultra-Rare’ Diseases
May 16, 2024 - Media Coverage
- Our Impact on Rare Diseases
Every Cure Gets $48 Million for AI-Powered Rare Disease Research
May 14, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Rare Disease Day at NIH 2024: Showcasing Voices and New Opportunities
April 23, 2024 - NCATS News
- Our Impact on Rare Diseases
The rare diseases community came together at Rare Disease Day at NIH to share inspiring stories, impactful research advances and exciting new possibilities for the future.
Families, Researchers Share Insights at Rare Disease Day
April 12, 2024 - Grantee/Partner News
- Our Impact on Rare Diseases
At a Symposium on Rare Diseases, Smiles Were in Abundance
March 28, 2024 - Grantee/Partner News
- Our Impact on Rare Diseases
Sharing Science and Stories at Rare Disease Day Symposium
March 7, 2024 - Grantee/Partner News
- Our Impact on Rare Diseases
NCATS-Funded Rare Disease Researchers Provide Key Data, Help Build New Kidney Atlas
February 29, 2024 - NCATS News
- Our Impact on Rare Diseases
- Rare Diseases Clinical Research Network (RDCRN)
NEPTUNE’s research has helped us learn more about the biology of both rare and common kidney diseases. It has also led to better ways to diagnose and treat these conditions.